Company Filing History:
3 out of 560 
1 out of 2,896 
Years Active: 2017-2023
Title: **Jose Baselga: A Pioneer in Cancer Treatment Innovations**
Introduction
Jose Baselga is a distinguished inventor and prominent figure in cancer research, located in New York, NY. With a remarkable portfolio of 4 patents, he has significantly contributed to the advancement of cancer therapeutics, particularly in developing targeted treatment strategies.
Latest Patents
One of Baselga's latest patents is focused on "Combination therapy using PDK1 and PI3K inhibitors." This invention outlines methods and compositions designed to inhibit the growth and proliferation of cancer cells resistant to PI3K inhibition. The innovative approach combines the use of PDK1, SGK1, and PI3K inhibitors, providing new avenues for treating resistant cancer cells effectively.
Another significant patent from Baselga is centered on "Inhibition of KMT2D for the treatment of cancer." This invention addresses the administration of a KMT2D inhibitor as a therapeutic strategy. The research reveals that KMT2D activity is upregulated upon PI3K inhibition, leading to increased expression of genes involved in breast cancer cell proliferation and tumor growth. The patent presents new methods for treating cancer by using a therapeutically effective amount of a KMT2D inhibitor.
Career Highlights
Jose Baselga has held influential roles in reputable organizations, notably at Memorial Sloan Kettering Cancer Center and The General Hospital Corporation. Throughout his career, he has focused on innovation and research in the field of oncology, making substantial impacts on treatment methodologies and patient outcomes.
Collaborations
Baselga has collaborated with esteemed colleagues such as Pau Castel and Maurizio Scaltriti. Their collective efforts have further propelled advancements in cancer treatment, enhancing the understanding and development of targeted therapies in oncology.
Conclusion
Jose Baselga's innovative contributions to cancer treatment through his patents demonstrate his commitment to improving therapeutic strategies. His work continues to inspire current and future research in the field of cancer, showcasing the vital role of inventors in addressing significant health challenges.